Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 81 EP752 | DOI: 10.1530/endoabs.81.EP752

ECE2022 Eposter Presentations Pituitary and Neuroendocrinology (211 abstracts)

Clinical presentation of non-functioning pituitary tumors: the experience at a tertiary care hospital in Portugal

Maria Inês Alexandre1, Ana Gomes1, 2, Ema Lacerda Nobre1, 2, Pedro Marques1, 2 & Maria Joao Bugalho1, 2


1Hospital Santa Maria, Endocrinology, Diabetes and Metabolism Department, Lisboa, Portugal; 2Faculty of Medicine, University of Lisbon, Lisboa, Portugal


Introduction: Clinically non-functioning pituitary tumors (NFPTs) lack clinical or biochemical evidence of pituitary hormone excess. Their clinical presentation is heterogeneous, including mass effect-related symptoms and/or hypopituitarism, or even no symptoms in incidentally-detected NFPTs. We aimed to evaluate the clinical presentation spectrum of NFPTs in a cohort of patients managed at our hospital.

Methods: Clinical, demographic, biochemical and imaging data from 227 patients was retrieved and retrospectively analyzed using SPSS®.

Results: Our cohort included 115 women (50.7%) and the median age of the study population was 58±15 years. Most patients had NFPT-related symptoms at presentation (75.3%), predominantly visual disturbances (56.8%) and headache (35.7%). In contrast, 56 patients (24.7%) had an incidental diagnosis on neuroimaging performed for other reasons, largely trauma (21.4%). Patients with incidentally-discovered NFPTs were significantly older than those with clinically-presenting NFPTs (62.8±14.2 vs 54.8±14.7; P=0.001). Regarding the entire group of patients, at diagnosis, the majority had one or more pituitary hormone deficiencies (55.9%), which occurred more frequently in men than women (66.1 vs 46.1%; P<0.001), in older patients and in patients with larger tumors (P<0.001). Of the 227 NFPTs, 210 (92.5%) were macroadenomas, and 180 (79.3%) had extrasellar extension. The mean diameter at diagnosis was 2.41±1.15 cm. Clinically-presenting patients had larger tumors (2.60 vs 1.97 cm; P=0.006). A total of 140 patients (61.7%) underwent surgery, 75.7% of these within the first 12 months since the NFPT diagnosis. The subgroup of incidentally-discovered NFPTs required less often an operation than the clinically-presenting counterparts (41.1 vs 68.4%; P<0.001).

Conclusion: Our NFPT cohort included patients who mostly presented with large tumors associated with compressive symptoms and hormonal deficiencies. However, a quarter of cases were incidentally-discovered NFPTs, typically found in older patients, and despite their smaller size still more than one third needed surgery.

Volume 81

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.